WIPIVERSE

Melengestrol

Melengestrol is a synthetic steroidal progestogen belonging to the 19‑norprogesterone family. It is most commonly encountered in its acetate ester form, melengestrol acetate (MGA), which is employed primarily in veterinary medicine.

Chemical Characteristics

  • IUPAC name: (8S,9R,10S,13S,14S,17S)-17‑acetoxy‑13‑methyl‑16‑methylene‑1,2,6,7,8,9,10,11,12,14,15,17‑dodecahydro‑cyclopenta$$a$$phenanthren‑3‑one.
  • Molecular formula: C₂₅H₃₄O₃ (for the acetate ester).
  • Molecular weight: 382.55 g mol⁻¹.
  • Structure: A 19‑nor‑progesterone skeleton with a 16‑methylene group and an acetoxy substituent at C‑17.

Pharmacology

Melengestrol acetate acts as a high‑affinity agonist of the progesterone receptor, exerting strong progestogenic activity while displaying minimal androgenic, estrogenic, or glucocorticoid effects. Its potency in suppressing estrus in livestock is comparable to that of other synthetic progestins such as megestrol acetate.

Veterinary Applications

  • Estrus suppression in cattle: MGA is administered orally, often mixed into feed, to inhibit the onset of estrus in heifers and mature cows. This facilitates synchronized breeding programs and improves herd management.
  • Growth promotion: In some jurisdictions, MGA has been used as a feed additive to enhance weight gain and feed efficiency in beef cattle, though such use is restricted or prohibited in many regions due to concerns about residues in meat.
  • Regulatory status: The use of melengestrol acetate in food‑producing animals is regulated by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Maximum residue limits (MRLs) are established to ensure food safety.

Metabolism and Residue Detection

Melengestrol acetate is metabolized primarily in the liver to inactive hydroxylated and conjugated metabolites, which are excreted via urine and feces. Analytical methods—including liquid chromatography–tandem mass spectrometry (LC‑MS/MS)—are employed to monitor residues in animal tissues and ensure compliance with MRLs.

Safety and Toxicology

  • Acute toxicity: Oral LD₅₀ values in laboratory rodents are above 2,000 mg kg⁻¹, indicating low acute toxicity.
  • Chronic exposure: Studies in target species have not demonstrated adverse effects on growth, reproduction (outside the intended progestogenic action), or organ health at approved dosage levels.
  • Human exposure: Humans may be exposed indirectly through consumption of meat from treated animals. Regulatory MRLs aim to keep any exposure well below established acceptable daily intakes (ADIs).

Synthesis

Melengestrol acetate is synthesized from progesterone or related steroid precursors through a series of chemical transformations that introduce the 19‑nor modification, the 16‑methylene double bond, and the 17‑acetoxy group. Commercial production utilizes established steroid chemistry protocols under Good Manufacturing Practice (GMP) conditions.

Legal and Ethical Considerations

The use of MGA as a growth promoter has been banned in the European Union since 1997, reflecting wider concerns about hormone residues in the food chain. In contrast, its role in estrus control remains permitted in several countries, provided that veterinary prescriptions and residue monitoring are followed.

References

  • FDA Center for Veterinary Medicine. Veterinary Drug Approval Package: Melengestrol Acetate. (2020).
  • European Medicines Agency. Assessment report for melengestrol acetate. (2005).
  • McNaughton, D., et al. “Pharmacokinetics and residue depletion of melengestrol acetate in cattle.” Journal of Veterinary Pharmacology and Therapeutics, vol. 28, no. 3, 2005, pp. 247‑254.

All information presented reflects the state of knowledge available from peer‑reviewed literature and regulatory documents up to the cutoff date.

Browse

More topics to explore

    Browse all articles